Breaking News Instant updates and real-time market news.

KROS

Keros Therapeutics

$27.61 /

+0.51 (+1.88%)

07:12
05/22/20
05/22
07:12
05/22/20
07:12

Keros Therapeutics expects cash, cash equivalents to fund operations into 2H22

Keros' cash and cash equivalents as of March 31, 2020 was $54.5M compared to $7M as of December 31, 2019. Total cash and cash equivalents as of March 31, 2020 did not include total net proceeds of approximately $99.8M from the Company's initial public offering completed in April 2020. Keros expects that the cash and cash equivalents it had on hand at March 31, 2020, together with the net proceeds from its initial public offering, will fund its operating expenses and capital expenditure requirements into the second half of 2022.

KROS Keros Therapeutics
$27.61 /

+0.51 (+1.88%)

05/04/20
Fly Intel: Top five analyst initiations
05/04/20 H.C. Wainwright
Keros Therapeutics initiated with a Buy at H.C. Wainwright
05/04/20 SVB Leerink
Keros Therapeutics initiated with an Outperform at SVB Leerink
05/04/20 Jefferies
Keros Therapeutics initiated with a Buy at Jefferies

TODAY'S FREE FLY STORIES

General news
Treasury's $150 B in 4- and 8-week bill auctions were fairly routine » 11:55
05/28/20
05/28
11:55
05/28/20
11:55

Treasury's $150 B in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General News
NY Governor Cuomo reports 74 virus deaths vs. 74 deaths the day before » 11:54
05/28/20
05/28
11:54
05/28/20
11:54
SPY

SPDR S&P 500 ETF Trust

$304.86 /

+1.34 (+0.44%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

In his daily COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPX S&P 500
$0.00 /

+ (+0.00%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$304.86 /

+1.34 (+0.44%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Conference/Events
Computer Programs participates in a conference call with Cantor Fitzgerald » 11:53
05/28/20
05/28
11:53
05/28/20
11:53
CPSI

Computer Programs

$22.81 /

+0.41 (+1.83%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPSI Computer Programs
$22.81 /

+0.41 (+1.83%)

CPSI Computer Programs
$22.81 /

+0.41 (+1.83%)

05/08/20 Cantor Fitzgerald
Computer Programs upgraded to Overweight from Neutral at Cantor Fitzgerald
05/06/20 Piper Sandler
Computer Programs price target lowered to $27 from $29 at Piper Sandler
04/14/20 KeyBanc
Computer Programs price target lowered to $20 from $26 at KeyBanc
04/13/20 SVB Leerink
Computer Programs initiated with an Outperform at SVB Leerink
CPSI Computer Programs
$22.81 /

+0.41 (+1.83%)

Recommendations
Croda price target raised to 4,100 GBp from 3,900 GBp at Credit Suisse » 11:49
05/28/20
05/28
11:49
05/28/20
11:49
COIHY

Croda International

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIHY Croda International
$0.00 /

+ (+0.00%)

04/21/20 Liberum
Croda International upgraded to Buy from Hold at Liberum
03/30/20 Morgan Stanley
Croda price target lowered to 5,000 GBp from 5,200 GBp at Morgan Stanley
03/24/20 JPMorgan
Croda price target lowered to 4,025 GBp from 4,500 GBp at JPMorgan
03/04/20 JPMorgan
Croda International price target lowered to 4,500 GBp from 4,700 GBp at JPMorgan
Conference/Events
MongoDB participates in a conference call with Cantor Fitzgerald » 11:49
05/28/20
05/28
11:49
05/28/20
11:49
MDB

MongoDB

$216.49 /

+4.7 (+2.22%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDB MongoDB
$216.49 /

+4.7 (+2.22%)

MDB MongoDB
$216.49 /

+4.7 (+2.22%)

05/22/20 Stifel
MongoDB price target raised to $225 from $160 at Stifel
04/19/20 Stifel
MongoDB price target raised to $160 from $135 at Stifel
03/18/20 Oppenheimer
MongoDB price target lowered to $140 from $155 at Oppenheimer
03/18/20 DA Davidson
MongoDB price target lowered to $105 from $143 at DA Davidson
MDB MongoDB
$216.49 /

+4.7 (+2.22%)

MDB MongoDB
$216.49 /

+4.7 (+2.22%)

MDB MongoDB
$216.49 /

+4.7 (+2.22%)

Hot Stocks
Robotics firm Nuro Partners with CVS on autonomous prescription deliveries » 11:47
05/28/20
05/28
11:47
05/28/20
11:47
CVS

CVS Health

$67.43 /

+1.46 (+2.21%)

In a recent blog post on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

Recommendations
GEA Group price target raised to EUR 22 from EUR 21 at Credit Suisse » 11:46
05/28/20
05/28
11:46
05/28/20
11:46
GEAGY

GEA Group

$0.00 /

+ (+0.00%)

Credit Suisse analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GEAGY GEA Group
$0.00 /

+ (+0.00%)

05/27/20 Deutsche Bank
GEA Group price target raised to EUR 19 from EUR 15 at Deutsche Bank
05/19/20 UBS
GEA Group price target lowered to EUR 27 from EUR 29 at UBS
05/19/20 JPMorgan
GEA Group price target raised to EUR 18.50 from EUR 16 at JPMorgan
05/18/20 Morgan Stanley
GEA Group price target raised to EUR 24 from EUR 22 at Morgan Stanley
Hot Stocks
Amazon offering 120,000 full-time jobs to seasonal employees » 11:46
05/28/20
05/28
11:46
05/28/20
11:46
AMZN

Amazon.com

$2,415.00 /

+4 (+0.17%)

Amazon said in a blog…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/18/20 Bernstein
Amazon not building standalone overnight network, says Bernstein
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/12/20 Barrington
Amazon interest in AMC 'not outside the realm of possibility,' says Barrington
AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

Conference/Events
Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call » 11:46
05/28/20
05/28
11:46
05/28/20
11:46

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
8-Week Bill Auction Total Amount data reported » 11:44
05/28/20
05/28
11:44
05/28/20
11:44

8-Week Bill Auction Total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
4-Week Bill Auction Total Amount data reported » 11:44
05/28/20
05/28
11:44
05/28/20
11:44

4-Week Bill Auction Total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Toll Brothers focused on growth in mountain states, South  11:44
05/28/20
05/28
11:44
05/28/20
11:44
TOL

Toll Brothers

$33.63 /

+0.685 (+2.08%)

 
ShowHide Related Items >><<
TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

On The Fly
Alexion rises as documents suggest settlement of Amgen patent challenge » 11:41
05/28/20
05/28
11:41
05/28/20
11:41
ALXN

Alexion

$115.45 /

+9.28 (+8.74%)

, AMGN

Amgen

$224.79 /

-0.02 (-0.01%)

, SNY

Sanofi

$48.89 /

+1.38 (+2.90%)

, REGN

Regeneron

$566.53 /

+22.52 (+4.14%)

Shares of Alexion (ALXN)…

Open Full Text

ShowHide Related Items >><<
ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

ALXN Alexion
$115.45 /

+9.28 (+8.74%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
08:48 Today Cowen
Alexion settlement may yield upside surprise, says Cowen
07:59 Today Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/26/20 BMO Capital
BMO Capital still sees favorable risk/reward in Alexion following Argenx news
AMGN Amgen
$224.79 /

-0.02 (-0.01%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
08:48 Today Cowen
Alexion settlement may yield upside surprise, says Cowen
07:59 Today Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
SNY Sanofi
$48.89 /

+1.38 (+2.90%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
REGN Regeneron
$566.53 /

+22.52 (+4.14%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
06:47 Today Barclays
Regeneron price target raised to $615 from $530 at Barclays
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20
Fly Intel: Top five analyst upgrades
ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

  • 27
    May
ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

ALXN Alexion
$115.45 /

+9.28 (+8.74%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

Options
Put spread purchase in High Yield Bond ETF likely closes » 11:40
05/28/20
05/28
11:40
05/28/20
11:40
HYG

iShares iBoxx $ High Yield Corporate Bond

$82.17 /

+0.16 (+0.20%)

Put spread purchase in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HYG iShares iBoxx $ High Yield Corporate Bond
$82.17 /

+0.16 (+0.20%)

HYG iShares iBoxx $ High Yield Corporate Bond
$82.17 /

+0.16 (+0.20%)

HYG iShares iBoxx $ High Yield Corporate Bond
$82.17 /

+0.16 (+0.20%)

Options
Royal Dutch Shell put volume heavy and directionally bearish » 11:35
05/28/20
05/28
11:35
05/28/20
11:35

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Energy Action: The weekly EIA inventory data » 11:35
05/28/20
05/28
11:35
05/28/20
11:35

Energy Action: The weekly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Driver Management calls ISS report on First United Corp 'flawed' » 11:34
05/28/20
05/28
11:34
05/28/20
11:34
FUNC

First United Corp

$14.70 /

+ (+0.00%)

Driver Management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$14.70 /

+ (+0.00%)

Hot Stocks
Aurora Cannabis completes acquisition of Reliva for approximately $40M in stock » 11:34
05/28/20
05/28
11:34
05/28/20
11:34
ACB

Aurora Cannabis

$16.50 /

+1.24 (+8.13%)

Aurora Cannabis announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

05/22/20 CIBC
Aurora Cannabis price target raised to C$24 from C$14 at CIBC
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Jefferies
Aurora Cannabis downgraded to Underperform from Hold at Jefferies
05/21/20 Stifel
Stifel keeps Sell rating on Aurora, calls Reliva deal a 'small but good step'
ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

Earnings
Fly Intel: What to watch in Salesforce earnings report » 11:33
05/28/20
05/28
11:33
05/28/20
11:33
CRM

Salesforce

$182.18 /

+5.61 (+3.18%)

, RTW

RTW Retailwinds

$0.44 /

-0.0174 (-3.80%)

, BBW

Build-A-Bear

$2.25 /

+0.04 (+1.81%)

Salesforce (CRM) is…

Salesforce (CRM) is scheduled to report results of its first fiscal quarter after the market close on Thursday, May 28, with a conference call scheduled for 5:00 pm ET. What to watch for: 1. GUIDANCE: Along with its fourth quarter earnings report, Salesforce set its fiscal year 2021 adjusted earnings per share view at $3.16-$3.18. Consensus for earnings, which was $3.10 at the time, has remained the same. The company also raised its 2021 revenue view to $21B-$21.1B from $20.8B-$20.9B. Consensus, which was $20.93B at the time, has dropped slightly to $20.77B. In addition, the company provided first quarter adjusted EPS guidance of 70c-71c on a revenue of $4.875B-$4.885B. Consensus for earnings, which was at 55c at the time, has risen to 69c, and estimates for revenue, which was at $4.84B, have increased to $4.85B. 2. CO-CEO STEPS DOWN: The company announced in February that Keith Block had stepped down as co-CEO of Salesforce and Marc Benioff would remain as Chair and CEO of the company. Additionally, Salesforce named Gavin Patterson, former BT Group CEO, its president and CEO of Salesforce International. 3. VLOCITY ACQUISITION: The company announced with its earnings report that it entered into an agreement to acquire Vlocity, a provider of industry-specific cloud and mobile software built natively on the Salesforce platform, for approximately $1.33B. The purchase price will be paid in cash and the assumption of outstanding unvested equity awards held by Vlocity employees. The acquisition is expected to close during Q2 of 2021, subject to customary closing conditions. 4. PARTNERSHIPS: RTW Retailwinds (RTW) announced in February a multi-year partnership for Salesforce to be its new digital ecommerce platform partner for all businesses, including New York & Company, Fashion to Figure, and Happy x Nature. Additionally in March, Salesforce announced an expanded relationship with Build-A-Bear Workshop (BBW) as its strategic partner in digital transformation. 5. ANALYST VIEWS: In May, Oppenheimer analyst Brian Schwartz raised the firm's price target on Salesforce to $195 from $165 and kept an Outperform rating on the shares. While the analyst acknowledges that the company is not immune from the COVID-19 issues, he believes the high priority SaaS enjoys across global enterprises is broadly unchanged. Jefferies analyst Brent Thill also raised the firm's price target on Salesforce to $205 from $180 and kept a Buy rating on the shares. The analyst noted that his survey of over 50 partners indicated that over 70% saw their CRM pipelines decrease due to the pandemic, but longer term, he sees its pipeline remaining robust. Additionally in May, RBC Capital analyst Alex Zukin lowered the firm's price target on Salesforce to $210 from $230 but kept an Outperform rating on the shares. The analyst said the company is not immune to the global demand trends, but he continues to see its Service Cloud, Commerce Cloud, Healthcare, FinServ and Contact Tracing efforts driving bookings momentum.

ShowHide Related Items >><<
CRM Salesforce
$182.18 /

+5.61 (+3.18%)

RTW RTW Retailwinds
$0.44 /

-0.0174 (-3.80%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

09:06 Today Needham
Workday price target raised to $200 from $175 at Needham
05/18/20 Jefferies
Salesforce price target raised to $205 from $180 at Jefferies
05/18/20 RBC Capital
Salesforce price target lowered to $210 from $230 at RBC Capital
05/18/20 Cowen
Salesforce price target lowered to $200 from $220 at Cowen
RTW RTW Retailwinds
$0.44 /

-0.0174 (-3.80%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

12/13/19 Jefferies
Removal, delay of China tariffs give 'reprieve' to toy companies, says Jefferies
CRM Salesforce
$182.18 /

+5.61 (+3.18%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

Hot Stocks
Toll Brothers saw highest deposit number since 2005 last week  11:26
05/28/20
05/28
11:26
05/28/20
11:26
TOL

Toll Brothers

$33.97 /

+1.025 (+3.11%)

 
ShowHide Related Items >><<
TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

Recommendations
Royal Bank of Canada price target raised to C$105 from C$97 at Scotiabank » 11:25
05/28/20
05/28
11:25
05/28/20
11:25
RY

Royal Bank of Canada

$66.17 /

-0.81 (-1.21%)

Scotiabank analyst Sumit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

10:43 Today Canaccord
Royal Bank of Canada price target raised to C$95 from C$86.50 at Canaccord
05/22/20 Scotiabank
Royal Bank of Canada price target lowered to C$97 from C$99 at Scotiabank
05/06/20 Citi
Royal Bank of Canada upgraded to Buy from Neutral at Citi
05/06/20 Citi
Royal Bank of Canada upgraded to Buy from Neutral at Citi
RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

Options
Chewy call volume above normal and directionally bullish » 11:25
05/28/20
05/28
11:25
05/28/20
11:25
CHWY

Chewy

$41.95 /

+1.83 (+4.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

04/20/20
Chewy cut to Neutral at UBS on longer term headwinds
04/20/20 UBS
Chewy downgraded to Neutral from Buy at UBS
04/17/20 Morgan Stanley
Chewy downgraded to Equal Weight following outperformance at Morgan Stanley
04/17/20 Credit Suisse
Chewy price target raised to $46 from $37 at Credit Suisse
CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

General news
Treasury announced a $117 B package of 3- and 6-month bill auctions for Monday » 11:25
05/28/20
05/28
11:25
05/28/20
11:25

Treasury announced a $117…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Varonis participates in a conference call with JMP Securities » 11:25
05/28/20
05/28
11:25
05/28/20
11:25
VRNS

Varonis

$85.00 /

+1.89 (+2.27%)

Cybersecurity & IT…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$85.00 /

+1.89 (+2.27%)

VRNS Varonis
$85.00 /

+1.89 (+2.27%)

05/05/20 DA Davidson
Varonis price target raised to $85 from $65 at DA Davidson
05/05/20 Craig-Hallum
Varonis downgraded to Hold at Craig-Hallum
05/05/20 Wedbush
Varonis price target lowered to $88 from $105 at Wedbush
05/05/20 Craig-Hallum
Varonis downgraded to Hold from Buy at Craig-Hallum
VRNS Varonis
$85.00 /

+1.89 (+2.27%)

VRNS Varonis
$85.00 /

+1.89 (+2.27%)

Conference/Events
BTIG life science/diagnostics analyst to hold analyst/industry conference call » 11:25
05/28/20
05/28
11:25
05/28/20
11:25

Life Science &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.